Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX000345-06 |
| Title: | Clinically Actionable Neoantigens in Non-Small Cell Lung Cancer |
| Principal Investigator: | Steven M. Dubinett |
| Location: | West Los Angeles, CA |
| Congressional District Code: | 33 |
| Research Service: | Clinical Science R&D |
| Project Period: | October 2017 - September 2021 |
| FY 2021 Funding Amount: | $300,000 |
| Total Award Amount (all years): |
$1,320,228 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Clinically actionable neoantigens in non-small cell lung cancer Lung cancer is the leading cause of cancer death among US Veterans as well as the world's leading cause of cancer death. Environmental exposure and tobacco use among Veterans operate together to increase risk. Unleashing the immune response against pulmonary premalignancy could transform therapy and outcomes. Here, we propose to lay the ground work for lung “cancer interception,” a strategy that seeks to block the progression of pre... |